These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9566484

  • 1. Iron monitoring and supplementation: how do we achieve the best results?
    Schaefer RM, Schaefer L.
    Nephrol Dial Transplant; 1998; 13 Suppl 2():9-12. PubMed ID: 9566484
    [Abstract] [Full Text] [Related]

  • 2. Iron metabolism in rhEPO-treated hemodialysis patients.
    Schaefer RM, Bahner U.
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809
    [Abstract] [Full Text] [Related]

  • 3. Erythropoietin and iron.
    Sunder-Plassmann G, Hörl WH.
    Clin Nephrol; 1997 Mar; 47(3):141-57. PubMed ID: 9105761
    [Abstract] [Full Text] [Related]

  • 4. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J, Lindner K, Schreiber M, Heidler RA, Hörl WH.
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iron status as measured by serum ferritin: the marker and its limitations.
    Cavill I.
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S12-7. PubMed ID: 10516370
    [Abstract] [Full Text] [Related]

  • 12. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Strategies for iron supplementation: oral versus intravenous.
    Macdougall IC.
    Kidney Int Suppl; 1999 Mar; 69():S61-6. PubMed ID: 10084288
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Erythrocyte zinc protoporphyrin.
    Braun J.
    Kidney Int Suppl; 1999 Mar; 69():S57-60. PubMed ID: 10084287
    [Abstract] [Full Text] [Related]

  • 18. Impact of parturition on iron status in nonanaemic iron deficiency.
    Krafft A, Huch R, Breymann C.
    Eur J Clin Invest; 2003 Oct; 33(10):919-23. PubMed ID: 14511365
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
    Cazzola M, Ponchio L, de Benedetti F, Ravelli A, Rosti V, Beguin Y, Invernizzi R, Barosi G, Martini A.
    Blood; 1996 Jun 01; 87(11):4824-30. PubMed ID: 8639855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.